The Impact of Mobile APP Intervention ( iCKD APP) on Chronic Kidney Disease Care
1 other identifier
interventional
101
1 country
1
Brief Summary
- Apply Mobile APP Intervention ( iCKD APP) to current chronic kidney disease care program.
- Conduct a randomized clinical trial to evaluate the clinical effectiveness of this mobile device on health behavior improvement in chronic kidney disease patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 26, 2018
CompletedFirst Submitted
Initial submission to the registry
August 7, 2018
CompletedFirst Posted
Study publicly available on registry
August 28, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2020
CompletedSeptember 2, 2021
August 1, 2019
2.2 years
August 7, 2018
August 31, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Compare clinics and home blood pressure
Systolic and diastolic blood pressure levels measured at both clinics and home will be compared between and within groups at various time points in study period.
3 months
Secondary Outcomes (2)
Achievement of Blood pressure control target
3 months
The monitor rate of Home Blood pressure
3 months
Study Arms (2)
iCKD APP Group
EXPERIMENTALUse iCKD APP
Traditional Care Group
NO INTERVENTIONAccept traditional care
Interventions
Eligibility Criteria
You may qualify if:
- Subjects are 20 years old and above, Chinese speaking, and able and willing to provide informed consent.
- Subjects own mobile devices such as cell phones and tablets.
- Subjects were diagnosed with Chronic Kidney Diseases and were taking a single antihypertensive agent for more than three months or they are not receiving treatment but with systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg.
You may not qualify if:
- starting dialysis or having a kidney transplant (RRT)
- participating in other interventional study
- cognitively impaired
- unable to give consent
- life expectancy less than 1 year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Shang-Jyh Hwang
Kaohsiung Medical University Chung-Ho Memorial Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 7, 2018
First Posted
August 28, 2018
Study Start
June 26, 2018
Primary Completion
August 31, 2020
Study Completion
August 31, 2020
Last Updated
September 2, 2021
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share